Quince Therapeutics, Inc.

Nasdaq:QNCX

Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA

The quince is the sole member of the genus Cydonia in the Malinae subtribe of the Rosaceae family. It is a deciduous tree that bears hard, aromatic bright golden-yellow pome fruit, similar in appearance to a pear.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/24/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
2/12/26	Q1 FY2026	→
11/12/25	Q4 FY2025	→
8/11/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/24/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
↓

News (8-K)

47 shown

Filed	Type	Description
2/2/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/29/26	Other	Other Events	→
10/17/25	Reg FD	Regulation FD Disclosure	→
9/26/25	Agreement	Entry into a Material Definitive Agreement	→
7/16/25	Reg FD	Regulation FD Disclosure	→
6/13/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

27 shown

Filed	Form	Description
10/17/25	424B5	424B5	→
8/5/25	424B5	424B5	→
7/25/25	S-3	S-3	→
4/23/25	ARS	ARS	→
3/24/25	S-8	S-8	→
3/24/25	424B5	424B5	→
↓

Filing History(401 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Mar 5, 2026

0000932540-26-000004

—

7.2 KB

8-K

Feb 12, 2026

0001193125-26-0475448-K

Feb 12, 2026

152.4 KB

8-K

Feb 2, 2026

0001193125-26-0337588-K

Jan 30, 2026

132.3 KB

8-K

Jan 29, 2026

0001193125-26-0295248-K

Jan 29, 2026

165.1 KB

Jan 23, 2026

0000912282-26-000121FORM 4

Jan 23, 2026

5.5 KB

Jan 23, 2026

0000912282-26-000120FORM 4

Jan 23, 2026

5.5 KB

Jan 23, 2026

0000912282-26-000119FORM 4

Jan 23, 2026

5.5 KB

Jan 21, 2026

0000912282-26-000089FORM 4

Jan 2, 2026

5.4 KB

Jan 21, 2026

0000912282-26-000087FORM 4

Jan 2, 2026

5.4 KB

Jan 21, 2026

0000912282-26-000085FORM 4

Jan 2, 2026

5.3 KB

Jan 21, 2026

0000912282-26-000083FORM 4

Jan 2, 2026

5.3 KB

144

Dec 29, 2025

0001628280-25-059050

—

4.7 KB

Dec 29, 2025

0000912282-25-001469FORM 4

Dec 26, 2025

5.4 KB

Dec 29, 2025

0000912282-25-001468FORM 4

Oct 23, 2024

5.3 KB

Dec 12, 2025

0000912282-25-001407FORM 4

Dec 10, 2025

5.9 KB

Dec 8, 2025

0000912282-25-001370FORM 4

Dec 5, 2025

10.4 KB

SCHEDULE 13G/A

Nov 14, 2025

0001104659-25-112623

—

11.2 KB

10-Q

Nov 12, 2025

0001193125-25-27752910-Q

Sep 30, 2025

12.2 MB

8-K

Nov 12, 2025

0001193125-25-2775238-K

Nov 12, 2025

465.9 KB

SCHEDULE 13G/A

Oct 30, 2025

0001140361-25-039832

—

15.3 KB

8-K

Oct 17, 2025

0001193125-25-2425148-K

Oct 17, 2025

135.6 KB

424B5

Oct 17, 2025

0001193125-25-242511424B5

—

69.6 KB

8-K

Sep 26, 2025

0001193125-25-2207228-K

Sep 25, 2025

135.6 KB

SCHEDULE 13G

Aug 14, 2025

0001104659-25-078682

—

11.1 KB

10-Q

Aug 11, 2025

0000950170-25-10653510-Q

Jun 30, 2025

12.1 MB

25 filings shown

Filed	Form	Description
4/23/25	DEFA14A	DEFA14A	→
4/23/25	DEF 14A	DEF 14A	→
4/9/25	PRE 14A	PRE 14A	→
4/24/24	DEFA14A	DEFA14A	→
4/24/24	DEF 14A	DEF 14A	→
4/11/24	PRE 14A	PRE 14A	→
↓

Quince Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(401 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/23/26	4	4	→
1/23/26	4	4	→
1/23/26	4	4	→
1/21/26	4	4	→
1/21/26	4	4	→
1/21/26	4	4	→
↓

Filed	Form	Description
3/5/26	SCHEDULE 13G	SCHEDULE 13G	→
12/29/25	144	144	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/30/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G	SCHEDULE 13G	→
8/5/25	EFFECT	EFFECT	→
↓